Navigation Links
FDA Sunscreen Labeling Decision Delayed Another Month, Leading U.S. Physician to Say, 'Enough Is Enough'
Date:11/29/2007

Dr. Karl Gruber Says New Rules for Sunscreen Are Necessary to Protect All

Consumers

LOS ANGELES, Nov. 29 /PRNewswire/ -- The U.S. Food and Drug Administration on Tuesday delayed its decision on adopting a new rule and rating system for over-the-counter sunscreen products, further delaying better sun protection for consumers everywhere, according to Dr. Karl Gruber, a surgical pathologist and expert in sun protection.

The new rule and rating system would require sunscreen manufacturers to provide more detailed information about their products' level of protection against damaging ultraviolet A (UVA) rays because the link between UVA exposure, melanoma and solar aging is compelling. The FDA has been wrestling with the UVA rule and rating issue and the need to update sunscreen regulations since 1999. On Tuesday, the agency extended its comment period on the proposed regulations to December 26, 2007.

"It is difficult to see how extending the comment period by a month for an issue that has been debated for eight years is going to make any difference -- except to deny consumers the information they need to make the best decisions about their own health," says Dr. Gruber, a physician who has studied carefully and fully endorses the FDA's proposed regulations.

Since 1978, over-the-counter sunscreen protection has been rated solely by SPF values, which only provides information on a product's level of protection from the sun's ultraviolet B (UVB) radiation that causes sunburn.

The American Academy of Dermatologists now recommends that consumers use a broad-spectrum sunscreen that blocks exposure to both UVA and UVB to help prevent skin cancer, the most prevalent of all types of cancers. More than 1 million new cases of skin cancer will be diagnosed in the U.S. this year alone, and more than 80 percent of these new cases could be prevented by protection from the sun's rays.(1)

Dr. Gruber regularl
'/>"/>

SOURCE LUCA Sunscreen
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. FDA Proposes New Rules for Sunscreens
2. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
3. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
4. IOM workshop on less confusing drug labeling, Oct. 12
5. GSK Revises US Labeling for Avandia(R)
6. Gerresheimer to be Included in the SDAX Early Decision on Inclusion in the MDAX on September 5, 2007
7. Microarray provides 3 genomic guides to breast cancer treatment decisions
8. Spectranetics to Appeal Decision in Patent Litigation
9. Canadas government funds $1.6M in modern geography to support public health decisions
10. Parents participation in medical decisions linked to self-efficacy
11. Decision-making by residents on-call has miniscule negative impact on patient care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... , SCOTTSDALE, Ariz., Dec. 4 He...naged, non-traded, real estate investment trust, a...ement to acquire a three building medical office p...Texas, and Fort Wayne, Indiana for approximately $...ject to the satisfaction of a number of conditions...
(Date:12/4/2009)... , WASHINGTON, Dec. 4 /PRNewswire-USNewswire/...orm would control health care costs, Leapfrog,s pu...rough example -- delivering the best quality care ...f efficiency. Thirty-four urban, eight children,s ...pfrog Top Hospitals, based on results from The Lea...
(Date:12/4/2009)...rking with mice, scientists at Johns Hopkins publi...own that a protein made by a gene called "Twist" m...distinguish stem cells that drive aggressive, meta...s. , Building on recent work suggesting that it ...ast tumors that drives breast cancer, scientists h...
(Date:12/4/2009)... Dental tourism is a phenomenon...an alternative to the high price of dental work in...rch for lower priced dental care, people have foun...s a dental tourist destination. , ...n business for more than 6 years, Mexican Dental V...
(Date:12/4/2009)..., BOSTON, Dec. 4 Substantial pr... healthcare community,s ability to diagnose and tr...ress in epilepsy management has not reached most o...g many of the nearly three million people in the U...g to Steven C. Schachter, M.D., president of the A...
Breaking Medicine News(10 mins):Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 4
...s, don,t take candy from strangers, expert says , ... Halloween right around the corner, many parents a...e. , According to Meridith Sonnett, director of p...nd safe occasion for everyone. , She particularly ...
...it , , FRIDAY, Oct. 31 (HealthDay News) --...earch shows that 40 percent of women report sexual...t it. , "The good news is that 12 percent is a ver...arvard Medical School and director of the Vincent ...
...e Guidance, HOUSTON, Oct. 31 Cyberonics, Inc. (N...Medicare and Medicaid Services,(CMS) has published...m,(OPPS) Final Rule and Ambulatory Payment Classif... generators and $7,234,for insertion of associated...
...ls attending four-day event, SAN DIEGO, Oct. 31 ...tal health issues, the 2008 U.S. Psychiatric and M... sessions today to major,depressive disorder and i...professionals attended,yesterday,s opening session...
... New Application of Tissue of,Origin Test, SUNNYV...cular diagnostics company focused on oncology, wil...ion based Pathwork(R) Tissue of Origin,Test at the...ary Tumor Site in Patients with Carcinoma of Unkno...
... LLC, a global,leader in manufacturing and product...dvanced and highly regulated industries, announced...n providing services and,products to the aerospace... CEO John Todd notes, "Customers all over the,worl...
Other Medicine News:Health News:Family Halloween Safety Can Be Fiendishly Simple 2Health News:Almost Half of Women Have Sexual Problems 2Health News:Almost Half of Women Have Sexual Problems 3Health News:Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS 2Health News:Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS 3Health News:Psychiatric Congress Focus on Depressive Disorders Continues Through the Weekend 2Health News:Pathwork Tissue of Origin Test Shows Potential to Aid in the Diagnosis of Cancer of Unknown Primary 2Health News:Pathwork Tissue of Origin Test Shows Potential to Aid in the Diagnosis of Cancer of Unknown Primary 3Health News:Intercim Announces Australia-Based Memko to Resell its Pertinence Suite Powered by Velocity in Asia Pacific 2
(Date:12/4/2009)...Dec. 4 Oxygen Biotherape...nced that the first patient has been enrolled in t... trial in Switzerland for use of Oxycyte(TM) emuls...e Company,s perfluorocarbon (PFC) therapeutic oxyg...ortance in improving the outcome of patients with ...
(Date:12/4/2009)..., LAKE FOREST, Ill., Dec. 4 /PRNewswire-FirstCall/... specialty pharmaceutical and medication delivery ...neration 50 mL and 100 mL VisIV(TM) containers for... now offers a complete size range (50 mL to 1 L) o...isIV product. The launch of the 50 mL and 100 mL c...
(Date:12/4/2009)..., HOUSTON, Dec. 4 OrthoAccel Techn...m , which is an acceleration device to enhance ort...tinuing Education course published by PennWell Co... many industries, including medicine and dentistry...dontic treatment, a summary of treatment biomechan...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4The Reduction of Eye Fatigue Improves Vision in Older Subjects 53740 1The Reduction of Eye Fatigue Improves Vision in Older Subjects 53740 2Multi state Medicare Fraud Crackdown Focuses Attention on Recovery Payoffs to Defray Health Reform Costs 53738 1Multi state Medicare Fraud Crackdown Focuses Attention on Recovery Payoffs to Defray Health Reform Costs 53738 2National Council on Disability to Call for Emergency Management Changes for People with Disabilities 53736 1
...ss.--(BUSINESS WIRE)--Apr 16, 2007 - Novelos,Thera...ompany,focused on the development of therapeutics ...t the company, in collaboration with,Dr. Kenneth T...sity,of South Carolina (MUSC), is making two poste...n for Cancer Research annual meeting.,These presen...
...--(BUSINESS WIRE)--Apr 16, 2007 - Antigenics Inc.,...n of updated data,from a Phase 1/2 investigator-sp...cer vaccine Oncophage(R) (vitespen) in,recurrent, ...e,American Association of Neurological Surgeons (A...study, being conducted at the,Brain Tumor Research...
Other Medicine Technology:Novelos Therapeutics and MUSC Present Two Posters at AACR 2007,Annual Meeting 2Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 2Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 3Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 4
Osher Lid Speculum
Cook Eye Speculum - Infant
Kawesch-Lancaster Eye Speculum
Knapp Eye Speculum
Medicine Products: